The competition in the field of people's life and health is becoming the main battlefield of technological competition among major powers. Developed countries and regions such as the United States, the United Kingdom, and the European Union are accelerating the development of basic research and cutting-edge emerging technologies in the field of biomedicine to ensure their sustained competitiveness globally. China urgently needs to seize the current major window of opportunity, place basic research in a more prominent position, and promote China's acceleration from a pharmaceutical manufacturing country to a pharmaceutical innovation powerhouse.
Strengthen top-level planning and improve the investment mechanism for basic research in biomedicine. Increase financial investment in basic research in biomedicine, and make forward-looking layouts and resource allocation in the fields of neuroscience, human microbiome, immunotherapy, gene editing, synthetic biology, stem cells, and regenerative medicine. Strive to achieve the goal of investing over 8% of basic research funds in the field of biomedicine during the 14th Five Year Plan period. Improve the mechanism of supporting basic research in biomedicine through the national science and technology plan and the national natural science foundation system, establish a dedicated national biomedical special fund, innovate project selection and funding methods, focus on the overall coordination between competitive and stable funding, and enhance the government's funding tilt towards the early transformation of high-quality basic research results. Encourage society and enterprises to invest and donate in basic research in biomedicine through tax reductions and exemptions.
